Evidence map›Paper›PMID 39137923›Full record

ArticleAIDS care2024

Examining HIV pre-exposure prophylaxis (PrEP) acceptability among rural people who inject drugs: predictors of PrEP interest among syringe service program clients.

Hilary L Surratt, Sarah Brown, Abby L Burton, Will Cranford, Christie Green, Stephanie M Mersch, Rebecca Rains, Philip M Westgate

Registry-linked trialAbstract read
In one paragraph

Article in AIDS care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05037513 (Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05037513 nacompletednot on this map

Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky

TypeinterventionalSponsorHilary L Surratt, PhDRan2021 to 2024Enrolled80ConditionsHIV PreventionArmsSBCM-PrEP, CDC-PrEP
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hilary L SurrattUniversity of Kentucky, Department of Behavioral Science, College of Medicine, Lexington, Kentucky, USA.
Sarah BrownAppalachian Regional Healthcare, Barbourville, Kentucky, USA.
Abby L BurtonUniversity of Kentucky, Department of Behavioral Science, College of Medicine, Lexington, Kentucky, USA.
Will CranfordUniversity of Kentucky, Department of Biostatistics, College of Public Health, Lexington, Kentucky, USA.
Christie GreenCumberland Valley District Health Department, Manchester, Kentucky, USA.
Stephanie M MerschUniversity of Kentucky, Department of Behavioral Science, College of Medicine, Lexington, Kentucky, USA.
Rebecca RainsKnox County Health Department, Barbourville, Kentucky, USA.
Philip M WestgateUniversity of Kentucky, Department of Biostatistics, College of Public Health, Lexington, Kentucky, USA.

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Integrated PrEP Interventions for People Who Inject Drugs in Rural KentuckyR34DA053140 · NIDA · UNIVERSITY OF KENTUCKY · PI SURRATT, HILARY L · 2021 to 2023
$655k
NCATS NIH HHS UL1 TR001998NIDA NIH HHS R34 DA053140
6 · The paper itself

Abstract

Rural communities in the US have increasing HIV burden tied to injection drug use, yet engagement in pre-exposure prophylaxis (PrEP) care has been low among people who inject drugs (PWID). Syringe service programs (SSPs) are widely implemented in Kentucky's Appalachian region, presenting an important opportunity to scale PrEP services. This paper examines PrEP awareness, interest and preferences among PWID attending community-based SSPs in Appalachia. Eighty participants were enrolled from two SSP locations. Eligibility included: ≥ 18 years old, current injection drug use and SSP use, and an indication for PrEP as defined by CDC guidelines. Participants completed a structured baseline interview. Predictors of PrEP awareness, interest and formulation preferences were examined. 38.8% reported baseline awareness of PrEP, 50% expressed high interest in PrEP, and 48.1%reported a preference for injectable PrEP. Significant bivariate predictors of PrEP interest included: current worry about health, higher perceived HIV risk, higher community HIV stigma, and higher enacted substance use stigma in the past year; in the adjusted model, enacted substance use stigma remained significant. Findings demonstrate substantial interest in PrEP among rural PWID. Intrapersonal and social determinant factors were associated with PrEP interest, which suggests the importance of multi-level intervention targets to increase PrEP uptake.

Indexed as

HIV InfectionsNeedle-Exchange ProgramsPatient Acceptance of Health CarePre-Exposure ProphylaxisRural PopulationSubstance Abuse, IntravenousAdultAnti-HIV AgentsAppalachian RegionFemaleHealth Knowledge, Attitudes, PracticeHumansKentuckyMaleMiddle AgedSocial StigmaAnti-HIV AgentsDrug injectionHIVmethamphetaminepre-exposure prophylaxisrural

Identifiers

PMID39137923
PMCPMC11560678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.